Skip to NavigationSkip to content

Parag Agarwal appointed as Dr Reddy’s Laboratories Chief Financial Officer

Published on: 30/10/20

Dr Reddy’s Laboratories has appointed Parag Agarwal has the company’s new Chief Financial Officer.

Parag has a career that spans 33 years and has held several leadership positions. 10 of these years have been spent working outside of India. He has expertise in driving performance management of investments, financial result delivery and driving operating margin improvement through revenue & cost optimization across the value chain.

He joins Dr Reddy’s from Reckitt Benckiser PLC, where he served as the Chief Financial Officer based in London. Prior to this, he was associated with organisations such as GSK Consumer Healthcare, Unilever and Genpact.

Commenting on his appointment, Agarwal said: “Dr Reddy’s is driven by its purpose, high governance standards, a robust strategy and strong leadership. I am truly excited to join the organization in its transformation journey to create even more value for its customers and patients.”

Agarwal will replace Saumen Chakraborty, the current CFO & President, who will retire on 1 December 2020. This follows over 19 years of service to the company where he contributed to functions such as HR, Global Generics Operations, Quality, Finance, Legal and Digital & Process Excellence. He will continue to be associated with the Company as an Advisor.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches